Previous 10 | Next 10 |
home / stock / ptgef / ptgef news
TORONTO , June 3, 2020 /PRNewswire/ - Portage Biotech Inc. (CSE: PBT.U) (OTC-Markets: PTGEF) ("Portage" or the "Corporation") wishes to announce that, further to its news release dated May 25, 2020 , the Corporation's common shares will commence trading on a one hundred (100) o...
Supports advancement of its immune-oncology programs Enables portfolio expansion/product acquisitions Intention to proceed with consolidation (reverse stock split) TORONTO , May 25, 2020 /PRNewswire/ - Portage Biotech Inc. (CSE: PBT.U, OTC Markets: PTGEF) ("Portage" or the "Compan...
TORONTO , May 12, 2020 /PRNewswire/ - Portage Biotech Inc. (PBT.U: CSE, PTGEF: OTC Markets) ("Portage" or the "Company") a leader in the early stage immune oncology space announced today the appointment of Allan L. Shaw to Chief Financial Officer at the Portage level and will assist in ...
Stimunity hits developmental milestone Developed systemic delivery for STING pathway Additional €900k invested TORONTO , May 11, 2020 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (Canadian Securities Exchange: PBT.U, OTC Markets : PTGEF...
TORONTO , May 5, 2020 /PRNewswire/ - (PBT.U: CSE, PTGEF: OTC Markets) - Portage Biotech Inc. ("Portage" or the "Company") wishes to provide an update on a subsidiary company, Saugatuck Therapeutics Ltd. ("Saugatuck"). Portage Biotech Inc. holds an 70% equity interest in Saugatuck. Porta...
Portage Announces Cease Trade Order Revoked; Update on Impact of COVID-19 on Operations Canada NewsWire TORONTO, April 16, 2020 TORONTO , April 16, 2020 /CNW/ - Portage Biotech Inc. (CSE:PBT.U, OTC Markets: PTGEF) ("Portage" or the "Company") wishes to announce that effec...
TORONTO , April 15, 2020 /PRNewswire/ - (PBT.U: CSE, PTGEF: OTC Markets) - Portage Biotech Inc. ("Portage" or the "Company") wishes to provide an update on a portfolio company, Intensity Therapeutics, Inc. ("Intensity"). Portage Biotech Inc. holds an 9.7% equity interest in Intensity...
Portage Files Business Acquisition Report Canada NewsWire TORONTO, April 6, 2020 TORONTO , April 6, 2020 /CNW/ - Further to its news release dated March 13, 2020 , Portage Biotech Inc. (CSE:PBT.U, OTC Markets: PTGEF) ("Portage" or the "Company") announces that, in a...
Portage Biotech ( OTC:PTGEF ): Q3 GAAP EPS of $0.00. More news on: Portage Biotech Inc., Earnings news and commentary, Energy stocks news, , Read more ...
TORONTO , March 13, 2020 /PRNewswire/ - Portage Biotech Inc. (PBT.U, OTC Markets: PTGEF) ("Portage" or the "Company") is pleased to announce that it has filed its third quarter financial statements and accompanying management and discussion. These documents are available on SEDAR and...
News, Short Squeeze, Breakout and More Instantly...
Portage Biotech Company Name:
PTGEF Stock Symbol:
OTCMKTS Market:
-- Company to advance three clinical-stage programs in pipeline -- -- Portage has received approval and is preparing for NASDAQ listing -- Toronto, Ontario--(Newsfile Corp. - February 11, 2021) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") today annou...
New York, New York--(Newsfile Corp. - December 1, 2020) - Portage Biotech (OTC Pink: PTGEF) (CSE: PBT.U) is an emerging biotechnology company developing an immunotherapy focused pipeline to treat a broad range of cancers. Unlike most biotechs though, Portage focuses on combining its own techno...
Toronto, Ontario--(Newsfile Corp. - October 16, 2020) - Portage Biotech Inc. (CSE: PBT.U) (OTC Pink: PTGEF) ("Portage" or the "Company") announces that the Company has filed its interim financial statements and related management's discussion and analysis for the three-month period ending June...